Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Waller

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Basic & Clinical Pharmacology & Toxicology|April 14, 2006
Making the most of spontaneous adverse drug reaction reportingPatrick C Waller
Pharmacoepidemiology and Drug Safety|March 6, 2003
A model for the future conduct of pharmacovigilancePatrick C Waller, Stephen J W Evans
British Journal of Clinical Pharmacology|January 26, 2006
Drug safety and the mediaPatrick C Waller, Stephen J W Evans, Keith Beard
Pharmacoepidemiology and Drug Safety|June 3, 2006
An analysis of the exclusion criteria used in observational pharmacoepidemiological studiesMichael Perrio, Patrick C Waller, Saad A W Shakir
BMJ (Clinical Research Ed.)|July 5, 2005
Drug safety and regulationPatrick C Waller, Stephen J W Evans, Keith Beard
Pharmacoepidemiology and Drug Safety|April 3, 2008
Developing tools for the safety specification in risk management plans: lessons learned from a pilot projectAndrew J P Cooper, Sally Lettis, Charlotte L Chapman, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Basic & Clinical Pharmacology & Toxicology|April 14, 2006
Making the most of spontaneous adverse drug reaction reportingPatrick C Waller
Pharmacoepidemiology and Drug Safety|March 6, 2003
A model for the future conduct of pharmacovigilancePatrick C Waller, Stephen J W Evans
British Journal of Clinical Pharmacology|January 26, 2006
Drug safety and the mediaPatrick C Waller, Stephen J W Evans, Keith Beard
Pharmacoepidemiology and Drug Safety|June 3, 2006
An analysis of the exclusion criteria used in observational pharmacoepidemiological studiesMichael Perrio, Patrick C Waller, Saad A W Shakir
BMJ (Clinical Research Ed.)|July 5, 2005
Drug safety and regulationPatrick C Waller, Stephen J W Evans, Keith Beard
Pharmacoepidemiology and Drug Safety|April 3, 2008
Developing tools for the safety specification in risk management plans: lessons learned from a pilot projectAndrew J P Cooper, Sally Lettis, Charlotte L Chapman, et al.
Pageof 1